End Prescription Drug Ads Now Act
- house
- senate
- president
Last progress July 22, 2025 (4 months ago)
Introduced on July 22, 2025 by Jerrold Lewis Nadler
House Votes
Referred to the House Committee on Energy and Commerce.
Senate Votes
Presidential Signature
AI Summary
This bill would stop drug companies from advertising prescription drugs directly to the public. That means no ads on TV, radio, magazines, websites, or social media that are aimed at consumers. If a company does run these ads, the drug would be treated as not allowed for sale under federal rules until they stop, effectively ending direct-to-consumer prescription drug ads.
The change starts 30 days after the law takes effect and applies to all prescription drugs, no matter when they were approved. In everyday life, you would likely see far fewer prescription drug ads, and information about medicines would come more from your doctor and official sources rather than from marketing.
Key points
- Who is affected: Prescription drug makers and the general public who see drug ads.
- What changes: Direct-to-consumer ads for prescription drugs are banned across TV, radio, print, digital platforms, and social media.
- When: The ban begins 30 days after the law is enacted and applies to all approved or licensed prescription drugs.